Marta Príncep

Marta Príncep PhD, holds 20 years of done-it background in management positions at the biomedical sector. She brings a long track record in drug discovery and development as Head of CNS dept at Ferrer Grupo creating new business and projects that led to several patent families, compounds in clinical phase and where she was member of the steering committee of international joint-ventures. Lately she performed as Innovation director and steering committee member at Biocat, the biocluster organization at Catalonia, where she was the scientific director of the Catalan business plan competition for start-ups, member of the Healthcare Investment Forum and director of the reference report on biosciences in Catalonia, fostering two public-private networks on oncology and nanomedicine among other activities. Nowadays she is the Technological Dpt director at Bellavista, a consultancy firm, in which she foster entrepreneurship and innovation, being board member in different start-ups and Strategic Advisor of Richi Research & CEO of the Biomarker and Drugs company created by Richi Foundation. Marta holds an industrial PhD in Biology and executive education from Wharton School in Pennsylvania and AMP from Esade Executive in Barcelona.